Featured Research

from universities, journals, and other organizations

Breast Cancer Subtypes Linked To Survival From Secondary Brain Tumors

Date:
March 1, 2008
Source:
BioMed Central/Breast Cancer Research
Summary:
Screening breast cancers for three receptors could help doctors predict the likely survival of patients with brain metastases. A new study shows that patients with tumours that are negative for estrogen receptor, progesterone receptor and human epidermal growth receptor-2 or that are HER2+/ER- appear to be most at risk from developing brain metastases. Survival is also correlated to the triple receptor status.

Screening breast cancers for three receptors could help doctors predict the likely survival of patients with brain metastases. A study published in the open access journal Breast Cancer Research shows that patients with tumours that are negative for estrogen receptor (ER), progesterone receptor (PR) and human epidermal growth receptor-2 (HER2) or that are HER2+/ER- appear to be most at risk from developing brain metastases. Survival is also correlated to the triple receptor status.

Related Articles


This is the first time that researchers have documented a possible link between breast cancer subtypes and the incidence and prognosis of brain metastases, which occur in up to one third of metastatic breast cancer patients.

A team from the National Cancer Centre in the Republic of Korea analysed data from 126 patients with brain metastases from a pool of 805 patients diagnosed with metastatic breast cancer and treated at the Centre. The presence or absence of ER, PR and HER2 were tested by immunohistochemical staining and/or fluorescent in situ hybridisation.

More than half of the patients with early (non-metastatic) breast cancer were of the luminal A subtype (ER or PR+ and HER2-). The proportion of patients with HER2+/ER- or triple-negative tumours was significantly higher among patients with brain metastases compared to the early breast cancer population, suggesting that these latter two subtypes were associated with the development of brain metastases.

The analysis also showed a correlation between the survival of patients and their triple receptor subtypes following the diagnosis of brain metastases, the survival time of which is just 3 -- 6 months. Patients with luminal A (4.0 months) and triple-negative tumours (3.4 months) had a similar shorter survival time compared with luminal B (ER or PR+ and HER2+; 9.2 months) and HER2+/ER- (5.0 months) tumours.

Patients with HER2-positive tumours experienced a significant survival benefit if they were treated with trastuzumab after their brain metastases were diagnosed.

"Our study suggests that the triple-negative subtype should be added to the list of risk factors for developing BM," remarks Jungsil Ro, the study's corresponding author. "Approximately 10-15% of all breast cancer presents this phenotype; they have a poor prognosis and are more likely to develop brain metastases. Triple receptor status can also help to predict survival even after brain metastases have been diagnosed. We now need to develop ways to screen for these subtypes and find the best ways to manage patients with this more aggressive phenotype."

Journal reference: Breast cancer subtypes and survival in patients with brain metastases. Byung-Ho Nam, Sun Young Kim, Hye-Suk Han, Youngmee Kwon, Keun Seok Lee, Tae Hyun Kim and Jungsil Ro. Breast Cancer Research (in press).


Story Source:

The above story is based on materials provided by BioMed Central/Breast Cancer Research. Note: Materials may be edited for content and length.


Cite This Page:

BioMed Central/Breast Cancer Research. "Breast Cancer Subtypes Linked To Survival From Secondary Brain Tumors." ScienceDaily. ScienceDaily, 1 March 2008. <www.sciencedaily.com/releases/2008/02/080227205118.htm>.
BioMed Central/Breast Cancer Research. (2008, March 1). Breast Cancer Subtypes Linked To Survival From Secondary Brain Tumors. ScienceDaily. Retrieved April 24, 2015 from www.sciencedaily.com/releases/2008/02/080227205118.htm
BioMed Central/Breast Cancer Research. "Breast Cancer Subtypes Linked To Survival From Secondary Brain Tumors." ScienceDaily. www.sciencedaily.com/releases/2008/02/080227205118.htm (accessed April 24, 2015).

Share This


More From ScienceDaily



More Health & Medicine News

Friday, April 24, 2015

Featured Research

from universities, journals, and other organizations


Featured Videos

from AP, Reuters, AFP, and other news services

85 Killed in Niger by Meningitis Since Start of Year

85 Killed in Niger by Meningitis Since Start of Year

AFP (Apr. 24, 2015) A meningitis outbreak in Niger has killed 85 people since the start of the year prompting authorities to close schools in the capital Niamey until Monday. Video provided by AFP
Powered by NewsLook.com
Anti-Malaria Jab Hope

Anti-Malaria Jab Hope

Reuters - News Video Online (Apr. 24, 2015) The world&apos;s first anti-malaria vaccine could get the go-ahead for use in Africa from October if approved by international regulators. Paul Chapman reports. Video provided by Reuters
Powered by NewsLook.com
3D Food Printing: The Meal of the Future?

3D Food Printing: The Meal of the Future?

AP (Apr. 23, 2015) Developers of 3D food printing hope the culinary technology will revolutionize the way we cook and eat. (April 23) Video provided by AP
Powered by NewsLook.com
Your Genes Could Influence How Much Mosquitoes Love You

Your Genes Could Influence How Much Mosquitoes Love You

Newsy (Apr. 23, 2015) New research suggests genetics play a big part in how appetizing you smell to mosquitoes. Video provided by Newsy
Powered by NewsLook.com

Search ScienceDaily

Number of stories in archives: 140,361

Find with keyword(s):
Enter a keyword or phrase to search ScienceDaily for related topics and research stories.

Save/Print:
Share:

Breaking News:

Strange & Offbeat Stories


Health & Medicine

Mind & Brain

Living & Well

In Other News

... from NewsDaily.com

Science News

Health News

Environment News

Technology News



Save/Print:
Share:

Free Subscriptions


Get the latest science news with ScienceDaily's free email newsletters, updated daily and weekly. Or view hourly updated newsfeeds in your RSS reader:

Get Social & Mobile


Keep up to date with the latest news from ScienceDaily via social networks and mobile apps:

Have Feedback?


Tell us what you think of ScienceDaily -- we welcome both positive and negative comments. Have any problems using the site? Questions?
Mobile: iPhone Android Web
Follow: Facebook Twitter Google+
Subscribe: RSS Feeds Email Newsletters
Latest Headlines Health & Medicine Mind & Brain Space & Time Matter & Energy Computers & Math Plants & Animals Earth & Climate Fossils & Ruins